|Articles|September 9, 2022

AJMC® in the Press, September 9, 2022

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A piece by BestLife referenced an article published on AJMC.com, the website of The American Journal of Managed Care^® (AJMC^®). The article, “Violence Against Healthcare Workers: A Rising Epidemic,” explored increasing rates of violence against employees in the field of health care.

An article by HealthDigest cited a report published in a supplement to AJMC^®, titled “Hyperhidrosis and Its Impact on Those Living With It.” The report discussed at-risk populations, symptoms involved, and the pathophysiology of hyperhidrosis.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related to this article

CAR T-cell Image | Image Credit: © Love Employee-stock.adobe.com

September 30th, 2026

Payers and Providers Map the Path to Community CAR T Access

CAR T-cell therapy must be treated as a complete "vein-to-vein" episode, with community practices needing to take control of cases for a period of time.

FDA approval | Image Credit: jittawit21 - stock.adobe.com

October 5th, 2026

FDA Approves First Heart Valve to Keep Pace With Children's Growth

The Autus Size-Adjustable Valve, which can be expanded as children grow, may reduce the need for repeat open-heart surgeries for congenital defects.

native indigenous cultures global | Image credit: Talita - stock.adobe.com

October 5th, 2026

Psoriasis Is Much Rarer in Indigenous Groups Worldwide

A scoping review of 15 studies found psoriasis prevalence markedly lower across 13 indigenous populations worldwide.

Health care cost | Image credit: digicomphoto - stock.adobe.com

October 5th, 2026

Traditional Medicare OOP Cap Could Lower Costs, Raise Federal Spending

A traditional Medicare out-of-pocket (OOP) cap could reduce beneficiaries’ costs but increase annual federal spending by $39 billion to $96 billion.

Lungs Image credit | Image credit: Rasi - stock.adobe.com

October 5th, 2026

Systemic Sclerosis Linked to Dramatic Rise in Lung Cancer Risk

A systemic sclerosis inception cohort and 17-study meta-analysis found a nearly 5-fold increase in lung cancer risk.

Pirtobrutinib’s first-line approval in chronic lymphocytic leukemia or small lymphocytic leukemia was based on data from the BRUIN CLL-313 trial. | Image credit: jittawit21 - stock.adobe.com

October 2nd, 2026

FDA Approves Pirtobrutinib for Untreated CLL/SLL Without 17p Deletion

This moves the noncovalent BTK inhibitor into the first-line setting for certain adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.